Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / BCRX - RBC cuts rating on BioCryst on disappointing BCX7353 data; down 4% premarket

BCRX - RBC cuts rating on BioCryst on disappointing BCX7353 data; down 4% premarket

BioCryst Pharmaceuticals Inc.
  • Cyclacel Pharmaceuticals (NASDAQ:CYCC) initiated with Buy rating and $8 (1173% upside) price target at Roth Capital Partners.
  • More news on: Cyclacel Pharmaceuticals, Inc., Dicerna Pharmaceuticals, Inc., Fate Therapeutics, Inc., Healthcare stocks news, , Stocks on the move,
    • Read more ...
Stock Information
Company Name: BioCryst Pharmaceuticals Inc.
Stock Symbol: BCRX
Market: NASDAQ
Website: biocryst.com
Menu
BCRX BCRX Quote BCRX Short BCRX News BCRX Articles BCRX Message Board
Get BCRX Alerts

News, Short Squeeze, Breakout and More Instantly...